A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
To study the maximum tolerated dose of Doxorubicin Hydrochloride Liposome Injection
combination with cyclophosphamide and sequential treatment of docetaxel for patients with
locally advanced breast cancer